AR and posterior cortical atrophy: This study aimed to provide an interim evaluation of the combination of androgen receptor signaling inhibitors denosumab, LRT, and metastasis‐directed therapy (MDT) for prostate cancer with multiple bone metastases (poly‐PCa).